Building Intricate Partnerships with Neurotechnology: Deep Brain Stimulation and Relational Agency

International Journal of Feminist Approaches to Bioethics 13 (1):134-154 (2020)
  Copy   BIBTEX

Abstract

Deep Brain Stimulation is an FDA-approved treatment for the symptoms of Parkinson's disease, essential tremor, dystonia, and epilepsy—with experimental use for mood disorders. DBS systems consist of a signal generator, typically implanted in the user's chest, that sends impulses to electrodes implanted in select areas of the user's brain. These signals change the activity of areas of the brain associated with unwanted symptoms. Several research groups have begun trials to use DBS as a treatment for psychiatric disorders. DBS, however, comes with a...

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,031

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Broader Challenges for DBS in the Treatment of Alzheimer's Disease.Robin Pierce - 2014 - American Journal of Bioethics Neuroscience 5 (4):81-83.
Relational Agency and Neurotechnology: Developing and Deploying Competency through Intricate Partnerships.Eliza Goddard - 2020 - International Journal of Feminist Approaches to Bioethics 13 (1):162-166.

Analytics

Added to PP
2020-03-20

Downloads
26 (#630,780)

6 months
12 (#242,943)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Timothy Emmanuel Brown
University of Washington

References found in this work

The extended mind.Andy Clark & David J. Chalmers - 1998 - Analysis 58 (1):7-19.
Agency.Markus Schlosser - 2015 - Stanford Encyclopedia of Philosophy.

View all 25 references / Add more references